PMC:7696151 / 46782-46997 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1327","span":{"begin":195,"end":198},"obj":"Chemical"},{"id":"1339","span":{"begin":116,"end":124},"obj":"Disease"},{"id":"1340","span":{"begin":146,"end":166},"obj":"Disease"}],"attributes":[{"id":"A1327","pred":"tao:has_database_id","subj":"1327","obj":"MESH:D006886"},{"id":"A1339","pred":"tao:has_database_id","subj":"1339","obj":"MESH:D003920"},{"id":"A1340","pred":"tao:has_database_id","subj":"1340","obj":"MESH:D001172"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, apparent different outcomes were derived from a randomized double-blind crossover trial, recruiting 23 non-diabetic subjects with stable rheumatoid arthritis to receive 6.5 mg/kg/day of HCQ for eight weeks."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T79","span":{"begin":146,"end":166},"obj":"Phenotype"}],"attributes":[{"id":"A79","pred":"hp_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/HP_0001370"}],"text":"However, apparent different outcomes were derived from a randomized double-blind crossover trial, recruiting 23 non-diabetic subjects with stable rheumatoid arthritis to receive 6.5 mg/kg/day of HCQ for eight weeks."}

{"project":"LitCovid-sentences","denotations":[{"id":"T301","span":{"begin":0,"end":215},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, apparent different outcomes were derived from a randomized double-blind crossover trial, recruiting 23 non-diabetic subjects with stable rheumatoid arthritis to receive 6.5 mg/kg/day of HCQ for eight weeks."}